Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma

Study Title

Efficacy/Safety Study of Nebulized IVX-0142, a Novel AntiFemale, Maleergic Drug, in Mild Female, Maleergic Asthma

Teva Identifier

IXR-201-04-142

ClinicalTrials.gov Identifier

NCT00232999

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Nebulized IVX-0142

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 60 Years

Trial Duration

10/01/2005 - 01/01/2006

Phase

Phase 2

Study Type

Interventional